Lido Advisors
MED icon

Lido Advisors’s Medifast MED Stock Holding History

Lido Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34M Buy
220,337
+37,302
+20% +$430K 0.01% 744
2026
Q1 		$1.87M Sell
183,035
-147,668
-45% -$1.59M 0.01% 732
2025
Q4 		$4.03M Hold
330,703
– – 0.01% 518
2025
Q3 		$4.52M Buy
+330,703
New +$4.62M 0.01% 467

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Lido Advisors's MED Position: Q2 2026 in Review

Lido Advisors increased its Medifast (MED) stake by 20% in Q2 2026, buying an estimated $430K and bringing the position to 220,337 shares worth $2.34M. The position accounts for 0.01% of the portfolio, ranked #744.

Lido Advisors first reported a position in MED in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.52M in Q3 2025. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Lido Advisors held 220,337 shares of Medifast worth $2.34M as of Q2 2026.
  • Lido Advisors bought 37,302 Medifast shares in Q2 2026, an estimated $430K.
  • Medifast made up 0.01% of Lido Advisors's portfolio in Q2 2026, its #744 holding.
  • Lido Advisors first reported a position in Medifast in Q3 2025 and has held it in 4 quarters since.
  • Lido Advisors's Medifast position peaked at $4.52M in Q3 2025.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.